nipradilol has been researched along with Myocardial Infarction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, M; Sonoki, H; Takeshita, A | 2 |
| Horimoto, H; Maeda, K; Mieno, S; Nakai, Y; Ohtsuka, T; Suematsu, Y; Takamoto, S | 1 |
| Izutani, S; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M | 1 |
| Inagaki, Y; Makita, K; Saito, T; Sekiya, T; Udaka, Y; Yamazaki, Y | 1 |
| Hieda, N; Ito, T; Ogawa, T; Ozawa, T; Satake, T; Sugiyama, S | 1 |
6 other study(ies) available for nipradilol and Myocardial Infarction
| Article | Year |
|---|---|
Chronic therapy with nipradilol, a beta-adrenergic blocker, attenuated left ventricular remodeling following myocardial infarction in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Female; Heart Rate; Myocardial Infarction; Propanolamines; Rats; Rats, Wistar; Ventricular Dysfunction, Left; Ventricular Pressure | 1997 |
Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Dilatation, Pathologic; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Myocardium; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Ventricular Function, Left; Ventricular Pressure | 1997 |
Long-term treatment with nipradilol, a nitric oxide-releasing beta-adrenergic blocker, enhances postischemic recovery and limits infarct size.
Topics: Adrenergic beta-Antagonists; Animals; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Propanolamines; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure | 2002 |
Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Biomarkers; Collagen Type I; Collagen Type III; Disease Models, Animal; Echocardiography, Doppler; Myocardial Infarction; Natriuretic Peptide, Brain; Propanolamines; Rats; Rats, Wistar; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2002 |
Effect of nipradilol on cardiovascular hemodynamics during exercise in angina pectoris with old myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Central Venous Pressure; Electrocardiography; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Propanolamines; Pulmonary Circulation; Ventricular Function, Left | 1992 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coronary Circulation; Coronary Disease; Dogs; Female; Glucuronidase; Heart Failure; Heart Rate; Lysosomes; Male; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Propanolamines; Propranolol; Ventricular Fibrillation | 1989 |